Results: 620

Effects of Chitosan Nanoparticles with Long Synthetic siRNAs Targeting VEGF in Triple-Negative Breast Cancer Cells

Abstract Vascular endothelial growth factor (VEGF) is an essential angiogenic factor in breast cancer development and metastasis. Small interfering RNAs (siRNAs) can specifically silence genes via the RNA interference pathway, therefore were investigated as cancer therapeutics. In this study, we investig...

Metastasis of Pulmonary Carcinoma to the Breast: Case Report

Introduction: Pulmonary carcinoma is the most prevalent cancer in the world, followed by breast cancer. It has high mortality rates in men and women mainly due to its ability to metastasize. Metastases from lung carcinoma to the breast are extremely rare. The first case described occurred in 1965 and sin...

Pituitary Metastasis Clinical Presentation of Diabetes Insipidus Six Years after Invasive Breast Carcinoma Diagnosis: Case Report

Introduction: Breast carcinomas are the major cause of death in women with cancer worldwide, mainly in metastatic cases. The pituitary gland stands for only 6-8% of the secondary sites of distant metastasis and it is usually asymptomatic. When symptomatic, these lesions can mimic primary pituitary diseas...

Espiritualidade e dor em pacientes com câncer de mama metastático

Rev. bioét. (Impr.); 31 (), 2023
Resumo Mediante estudo observacional, transversal e quantitativo que utilizou os instrumentos de avaliação Brief Pain Inventory (dor), Functional Assessment of Chronic Illness Therapy Spiritual Well-Being (bem-estar espiritual) e Beck Depression Inventory - Short Form (depressão), busca-se avaliar a i...

Pituitary Metastasis Clinical Presentation of Diabetes Insipidus Six Years after Invasive Breast Carcinoma Diagnosis: Case Report

Breast carcinomas are the major cause of death in women with cancer worldwide, mainly in metastatic cases. The pituitary gland stands for only 6-8% of the secondary sites of distant metastasis and it is usually asymptomatic. When symptomatic, these lesions can mimic primary pituitary diseases. Case repor...

Ameloblastoma metastásico

Repert. med. cir; 32 (1), 2023
77REPERT MED CIR. 2023;32(1):77-80Mario Alexander Melo MD*María Camila PiñerosbAna María TorresbFabián Parra F. MDcRafael Baracaldo A. MDda Patología. Grupo de Patología Oncológica, Instituto Nacional de Cancerología, Universidad El Bosque. Bogotá DC, Colombia. b Odontólogía, Patología Oral y...

Osteonecrosis maxilar asociada con altas dosis de antirresortivos en paciente oncolólgico adulto mayor: resolución interdisciplinaria de caso clínico
Osteonecrosis of the jaw associated with high doses of antiresorptive in an elderly cancer patient: interdisciplinary resolution of a clinical case

La osteonecrosis maxilar relacionada con medicamentos (ONMM) es una patología de características clínicas objetivas con signo-sintomatología patogno-mónica. El criterio clínico aceptado es la presencia de hueso necrótico expuesto y visible sobre el reborde óseo maxilar que no ha cicatrizado ...

Achados de ressonância magnética de metástase de rabdomiossarcoma para mama: relato de caso e revisão da literatura

Clin. biomed. res; 43 (3), 2023
Reportamos um caso de uma paciente do sexo feminino, 17 anos, com grande massa mamária palpável e história prévia de rabdomiossarcoma orbitário diagnosticado 18 meses antes. Após exames de imagem e biópsia percutânea, foi realizado o diagnóstico de metástase de rabdomiossarcoma do tipo alveolar...

Factores de riesgo asociados a metástasis en pacientes con cáncer de próstata: Un estudio observacional de centro único

Oncología (Guayaquil); 32 (3), 2022
Introducción: El cáncer de próstata (CP) el segundo cáncer diagnosticado en hombres, con mayor incidencia a los 66 años. La obesidad, el tabaquismo, alcoholismo y antecedentes familiares de CP se han encontrado asociados al riesgo de metástasis. El objetivo del presente estudio fue medir la aso-cia...

Cordoma sacral metastático

Os cordomas sacrais (CS) são tumores ósseos malignos primários da coluna vertebral de ocorrência rara, com incidência entre 0,000005-0,000027%. O objetivo deste estudo é relatar um caso de CS metastático. Homem de 41 anos, sem comorbidades, chega ao serviço de referência apresenta...